People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tarveda Therapeutics, Inc. | — | Biotechnology | Series B | $127.4M | $141.9M | 2020 |
| Rani Therapeutics, LLC | — | Biotechnology | Series C | $111.8M | $1.8B | 2020 |
| Rani Therapeutics Holdings, Inc. | — | Biotechnology | Series C | $60.3M | $326.1M | 2025 |
| Taris Biomedical Inc | — | Biotechnology | Series B | $36.9M | $535.8M | 2009 |
Dennis Ausiello at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dennis Ausiello on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mir Imran | 2 | 6 |
| Mir Hashim | 2 | 2 |
| Svai Sanford | 2 | 2 |
| Robert Langer | 1 | 36 |
| Kevin Bitterman | 1 | 15 |
| Michael Greeley | 1 | 15 |
| Peter Barton Hutt | 1 | 14 |
| Robert S Langer | 1 | 14 |
| Robert Crane | 1 | 7 |
| Brian Roberts | 1 | 7 |
| James Barrett | 1 | 6 |
| Diane Marcou | 1 | 5 |
| Cary Pfeffer | 1 | 4 |
| Christine Bunt | 1 | 4 |
| Nilesh Kumar | 1 | 4 |
| Michael Cima | 1 | 4 |
| Andrew Farquharson | 1 | 4 |
| Omid Farokhzad | 1 | 4 |
| Abraham Bassan | 1 | 4 |
| EDWIN M. KANIA | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.